Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients

Clinical Immunology

Volumn 128, Issue 3, 2008, Pages 400-408

  Chen, Zhiao ^a   Cheng, Yuming ^a   Xu, Yongfen ^a   Liao, Jing ^a   Zhang, Xiaonan ^a   Hu, Yunwen ^a   Zhang, Qin ^a   Wang, Jiefei ^a   Zhang, Zhanqing ^a   Shen, Fang ^a   Yuan, Zhenghong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cytokine; Hepatitis B virus; Peripheral blood mononuclear cells; Toll like receptors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ADULT; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 6;

EID: 49149128080     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.04.006     Document Type: Article

References (27)

1. Ganem D., and Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350 (2004) 1118-1129
2. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (2005) 215-229
3. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A.D., Giuberti T., Cavalli A., Petit M.A., and Fiaccadori F. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145 (1990) 3442-3449
4. Rehermann B., Fowler P., Sidney J., Person J., Redeker A., Brown M., Moss B., Sette A., and Chisari F.V. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181 (1995) 1047-1058
5. Thimme R., Wieland S., Steiger C., Ghrayeb J., Reimann K.A., Purcell R.H., and Chisari F.V. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77 (2003) 68-76
6. Visvanathan K., Skinner N.A., Thompson A.J., Riordan S.M., Sozzi V., Edwards R., Rodgers S., Kurtovic J., Chang J., Lewin S., Desmond P., and Locarnini S. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45 (2007) 102-110
7. Hui C.K., Zhang H.Y., Lee N.P., Yueng Y.H., Lu L., Leung N., Ho A., Ling M., Wong B.C., Lo C.M., Fan S.T., Luk J.M., and Lau G.K. Upregulation of toll-like receptor 7 is essential for serological clearance of hepatitis B surface antigen in chronic hepatitis B virus (HBV) infection. Hepatology 42 (2005) 707A
8. Naito H., Hayashi S., and Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J. Clin. Microbiol. 39 (2001) 362-364
9. Holmlund U., Cebers G., Dahlfors A.R., Sandstedt B., Bremme K., Ekstrom E.S., and Scheynius A. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 107 (2002) 145-151
10. Nagase H., Okugawa S., Ota Y., Yamaguchi M., Tomizawa H., Matsushima K., Ohta K., Yamamoto K., and Hirai K. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171 (2003) 3977-3982
11. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13766-13771
12. Pasare C., and Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Microbes. Infect. 6 (2004) 1382-1387
13. Boehme K.W., and Compton T. Innate sensing of viruses by toll-like receptors. J. Virol. 78 (2004) 7867-7873
14. Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., and Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 79 (2005) 12273-12279
15. Machida K., Cheng K.T., Sung V.M., Levine A.M., Foung S., and Lai M.M. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 80 (2006) 866-874
16. Li H., Zhang J., Kumar A., Zheng M., Atherton S.S., and Yu F.S. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 117 (2006) 167-176
17. Hasan U.A., Bates E., Takeshita F., Biliato A., Accardi R., Bouvard V., Mansour M., Vincent I., Gissmann L., Iftner T., Sideri M., Stubenrauch F., and Tommasino M. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 178 (2007) 3186-3197
18. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., Endres S., and Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 (2002) 4531-4537
19. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
20. Liu C.J., Kao J.H., and Chen D.S. Therapeutic implications of hepatitis B virus genotypes. Liver. Int. 25 (2005) 1097-1107
21. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118 (2000) 554-559
22. Orito E., Mizokami M., Sakugawa H., Michitaka K., Ishikawa K., Ichida T., Okanoue T., Yotsuyanagi H., and Iino S. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology. 33 (2001) 218-223
23. Janeway C.A., Travers P., Walport M., and Shlomchik M.J. Immunobiology: The Immune System in Health and Disease (2005), Garland Science Publishing
24. McClary H., Koch R., Chisari F.V., and Guidotti L.G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74 (2000) 2255-2264
25. Biermer M., Puro R., and Schneider R.J. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J. Virol. 77 (2003) 4033-4042
26. Puro R., and Schneider R.J. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J. Virol. 81 (2007) 7351-7362
27. Stoop J.N., Woltman A.M., Biesta P.J., Kusters J.G., Kuipers E.J., Janssen H.L., and van der Molen R.G. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response. Hepatology 46 (2007) 699-705